Showing results (141-150 of 219) with videos related to
Sort By:
Pageof 22
The Journal of Infectious Diseases|April 6, 2005
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disordersPhilip E Tarr, Patrick Taffé, Gabriela Bleiber, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2011
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinationsViktor von Wyl, Sabine Yerly, Jürg Böni, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2009
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in SwitzerlandViktor von Wyl, Sabine Yerly, Philippe Bürgisser, et al.Antiviral Therapy|June 3, 2010
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort StudyCatia Marzolini, Luigia Elzi, Sara Gibbons, et al.The Journal of Infectious Diseases|April 6, 2021
Impact of Delaying Antiretroviral Treatment During Primary Human Immunodeficiency Virus Infection on Telomere LengthMarieke Raffenberg, Tanja Engel, Isabella C Schoepf, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2011
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitorsAlexandra U Scherrer, Viktor von Wyl, Jürg Böni, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2010
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individualsMargalida Rotger, Thomas Gsponer, Raquel Martinez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovirViktor von Wyl, Sabine Yerly, Jürg Böni, et al.Plos One|June 22, 2012
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patientsAlexandra U Scherrer, Bruno Ledergerber, Viktor von Wyl, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.Pageof 22